Sector: Consumer Non-Cyclicals | Industry: Household Products |
See Regulatory Filings on SEC |
Company Contact | |
Address: | 1221 Broadway OAKLAND CA 94612-1888 |
Tel: | 1-510-2717767 |
Website: | https://www.thecloroxcompany.com |
IR: | See website |
Key People | ||
Linda J. Rendle Chairman of the Board, Chief Executive Officer | Matt Gregory Senior Vice President, Chief Customer Officer | Kevin B. Jacobsen Chief Financial Officer, Executive Vice President |
Chris T. Hyder Group President '�� Health and Hygiene | Eric H. Reynolds Chief Operating Officer, Executive Vice President | Kirsten M. Marriner Chief People and Corporate Affairs Officer, Executive Vice President |
Stacey Grier Executive Vice President - Chief Growth & Strategy Officer | Angela Christine Hilt Executive Vice President, Chief Legal Officer | Chau Banks Senior Vice President, Chief Information Officer and Data Officer | Eric Sean Schwartz Senior Vice President, Chief Marketing Officer |
Business Overview |
The Clorox Company is a multinational manufacturer and marketer of consumer and professional products. The Company operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment consists of cleaning, disinfecting and professional products mainly marketed and sold in the United States. The Household segment consists of bags and wraps, cat litter and grilling products marketed and sold in the United States. The Lifestyle segment consists of food, natural personal care products and water-filtration products marketed and sold in the United States. The International consists of products sold outside the United States. The products within International segment include laundry additives; home care products; water-filtration products; digestive health products; grilling products; cat litter; food; bags and wraps; natural personal care products; and professional cleaning and disinfecting products. |
Financial Overview |
For the nine months ended 31 March 2024, Clorox Co revenues decreased 3% to $5.19B. Net income totaled $64M vs. loss of $27M. Revenues reflect Health and Wellness segment decrease of 8% to $1.83B, Household segment decrease of 5% to $1.35B. Net Income reflects Impairment of Goodwill decrease from $445M (expense) to $0K, Restructuring and related costs decrease of 85% to $5M (expense). |
Employees: | 8,100 as of Mar 31, 2024 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $20,174M as of Mar 31, 2024 |
Annual revenue (TTM): | $7,209M as of Mar 31, 2024 |
EBITDA (TTM): | $1,257M as of Mar 31, 2024 |
Net annual income (TTM): | $240.00M as of Mar 31, 2024 |
Free cash flow (TTM): | -$22.00M as of Mar 31, 2024 |
Net Debt Last Fiscal Year: | $2,372M as of Mar 31, 2024 |
Shares outstanding: | 124,188,188 as of Apr 16, 2024 |
Index Membership: | S&P 500 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |